Effect of Injecting Primary Myoblasts Versus Putative Muscle-Derived Stem Cells on Mass and Force Generation inmdxMice
- 10 June 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 13 (9), 1081-1090
- https://doi.org/10.1089/104303402753812485
Abstract
It is well established that the injection of normal myoblasts or of muscle-derived stem cells (MDSCs) into the muscle of dystrophin-deficient mdx mice results in the incorporation of a number of donor myoblasts into the host muscle. However, the effect of the injected exogenous cells on mdx muscle mass and functional capacity has not been evaluated. This study evaluates the mass and functional capacity of the extensor digitorum longus (EDL) muscles of adult, male mdx mice that received intramuscular injections of primary myoblasts or of MDSCs (isolated by a preplating technique; Qu, Z., Balkir, L., van Deutekom, J.C., Robbins, P.D., Pruchnic, R., and Huard, J., J. Cell Biol. 1998;142:1257-1267) derived from normal mice. Evaluations were made 9 weeks after cell transplantation. Uninjected mdx EDL muscles have a mass 50% greater than that of age-matched C57BL/10J (normal) EDL muscles. Injections of either primary myoblasts or MDSCs have no effect on the mass of mdx EDL muscles. EDL muscles of mdx mice generate 43% more absolute twitch tension and 43% less specific tetanic tension then do EDL muscles of C57BL/10J mice. However, the absolute tetanic and specific twitch tension of mdx and C57BL/10J EDL muscles are similar. Injection of either primary myoblasts or MDSCs has no effect on the absolute or specific twitch and tetanic tensions of mdx muscle. Approximately 25% of the myofibers in mdx EDL muscles that received primary myoblasts react positively with antibody to dystrophin. There is no significant difference in the number of dystrophin-positive myofibers when MDSCs are injected. Regardless of the source of donor cells, dystrophin is limited to short distances (60-900 μm) along the length of the myofibers. This may, in part, explain the failure of cellular therapy to alter the contractile properties of murine dystrophic muscle.Keywords
This publication has 55 references indexed in Scilit:
- Dystrophin expression in the mdx mouse restored by stem cell transplantationNature, 1999
- How does dystrophin deficiency lead to muscle degeneration? — Evidence from the MDX mouseNeuromuscular Disorders, 1995
- Skeletal muscle satellite cellsReviews of physiology, biochemistry and pharmacology, 1994
- Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx miceMuscle & Nerve, 1992
- Transient neonatal denervation alters the proliferative capacity of myosatellite cells in dystrophic (129ReJdy/dy) muscleJournal of Neurobiology, 1992
- Formation of new muscle fibres and tumours after injection of cultured myogenic cellsJournal of Neurocytology, 1991
- Invited review: Myoblast transfer: A possible therapy for inherited myopathies?Muscle & Nerve, 1991
- Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblastsNature, 1989
- Clonal analysis of vertebrate myogenesis: I. Early developmental events in the chick limbDevelopmental Biology, 1974
- NATURE OF DIVIDING NUCLEI IN SKELETAL MUSCLE OF GROWING RATSThe Journal of cell biology, 1970